Showing results (521-530 of 662) with videos related to
Sort By:
Pageof 67
Brain : a Journal of Neurology|May 7, 2020
Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signatureMagdalena Przybyla, Janet van Eersel, Annika van Hummel, et al.Frontiers in Immunology|November 13, 2023
Modeling complement activation on human glomerular microvascular endothelial cellsKes H Stevens, Laura M Baas, Thea J A M van der Velden, et al.Acta Psychiatrica Scandinavica|September 3, 2011
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosisS Dragt, D H Nieman, F Schultze-Lutter, et al.Diabetologia|January 27, 2012
Confirmation of novel type 1 diabetes risk loci in familiesJ D Cooper, J M M Howson, D Smyth, et al.Space Science Reviews|July 17, 2018
Michelson Interferometer for Global High-resolution Thermospheric Imaging (MIGHTI): Instrument Design and CalibrationChristoph R Englert, John M Harlander, Charles M Brown, et al.Neuron|February 17, 2024
Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia miceYazi D Ke, Annika van Hummel, Carol Au, et al.Public Health|May 23, 2024
The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statementC Cook, L Reid, A M Elsharkawy, et al.Journal of Neuroinflammation|May 2, 2026
ALS-FTD-linked CCNFS621G drives increased hippocampal astrocyte ramification and mitochondrial dysfunction and impairs motor neuron excitabilityLiam Robinson, Dzung Do-Ha, Flora Cheng, et al.Nature Genetics|October 5, 2001
Haplotype tagging for the identification of common disease genesG C Johnson, L Esposito, B J Barratt, et al.Cancer Research|January 7, 2026
Defective DNA Damage Response is a Targetable Therapeutic Vulnerability in ESR1 Mutant Breast CancerSarah K Herzog, Jessica H Stevens, Guowei Gu, et al.Pageof 67